Cargando…
More Robust Evidence and Safety Checks are Required Before Autologous Serum Therapy as Treatment for Chronic Urticaria can be Recommended
Autor principal: | Khan, Sujoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726885/ https://www.ncbi.nlm.nih.gov/pubmed/23919009 http://dx.doi.org/10.4103/0019-5154.113964 |
Ejemplares similares
-
Urticaria in patients with diabetes: Adverse drug reaction or relapse of underlying autoimmune urticaria?
por: Khan, Sujoy
Publicado: (2019) -
CYCLOSPORINE IN CHRONIC IDIOPATHIC URTICARIA WITH POSITIVE AUTOLOGOUS SERUM SKIN TEST
por: Godse, K V
Publicado: (2008) -
Autologous Serum Therapy in Chronic Urticaria
por: Patil, Sharmila, et al.
Publicado: (2013) -
Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023) -
Exercise-induced urticaria, cholinergic urticaria, and Kounis syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2016)